Clinical Trials in Arizona

Showing 11521-11540 of 14,395 trials

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

NCT01300533

The goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014 that can be given in the treatment of patients with advanced or metastatic cancer.

Metastatic CancerCancerSolid Tumors

BIND Therapeutics58 participantsStarted Jan 2011

Scottsdale, Arizona, United States • Greenbrae, California, United States • Los Angeles, California, United States +3 more locations

COMPLETEDPhase 331 miles

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NCT00806546

This study will use an open-label design to evaluate the safety of NP101. Adult subjects who meet the enrollment criteria will be treated with NP101 (sumatriptan succinate iontophoretic transdermal patch) for acute migraine attacks over a 12 month period.

Migraine Disorders

NuPathe Inc.514 participantsStarted Feb 2009

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Irvine, California, United States +28 more locations

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

Find Trials by Condition in Arizona

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Relapse Prevention Study in Newly Abstinent Smokers

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

AqueSys Microfistula Implant in Refractory Glaucoma

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

TearLab Refractive Surgery Dry Eye Study

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)